SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-080025
Filing Date
2023-07-11
Accepted
2023-07-11 17:13:55
Documents
5
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2319588d2_def14a.htm DEF 14A 145509
2 GRAPHIC tm2319588d2_def14aimg001.jpg GRAPHIC 4934
3 GRAPHIC tm2319588d2_def14aimg002.jpg GRAPHIC 9507
4 GRAPHIC tmb-20230711xcoverg001.jpg GRAPHIC 98356
5 GRAPHIC tmb-20230711xcoverg002.jpg GRAPHIC 100354
  Complete submission text file 0001104659-23-080025.txt   440787
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 231082750
SIC: 2834 Pharmaceutical Preparations